Evaluation of Neuromuscular Blockade Responses in Statin-Using and Non-Using Patients
Launched by ANKARA CITY HOSPITAL BILKENT · Feb 15, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how certain medications called statins, which are commonly used to lower cholesterol, affect muscle relaxation during surgery. When patients undergo general anesthesia for elective surgeries, their muscles are often relaxed using a method called neuromuscular blockade. The study will compare patients who have been using statins for at least three months with those who have not used them at all. The researchers want to find out if statin use changes how deeply the muscles are relaxed, how long it takes for them to recover, and whether any muscle relaxation remains after surgery.
To participate in this study, you need to be between 18 and 75 years old, in good health (classified as ASA I, II, or III), and have a body mass index (BMI) between 18 and 30. You should also be scheduled for surgery that requires general anesthesia. If you have certain health issues, such as severe liver or kidney problems, respiratory disorders, or a history of certain muscle disorders, you may not be eligible. Participants will be asked to sign a consent form, and during the study, they will be monitored closely to assess how well their muscles respond to the anesthesia. This research aims to improve our understanding of how statins may impact muscle function during surgeries, which can help doctors provide better care for their patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-75 years
- • ASA classification I, II, III
- • BMI 18-30
- • Statin use for at least 3 months or no prior statin use
- • Elective surgery requiring general anesthesia with endotracheal intubation
- • Signed informed consent for participation in the study
- Exclusion Criteria:
- • ASA classification IV or higher
- • BMI \<18 or \>30
- • History of liver or renal insufficiency (creatinine \>1.6, liver function tests \>2x normal)
- • Neuromuscular, psychiatric, or neurological disorders
- • Pregnancy
- • Use of drugs affecting neuromuscular function (e.g., anticonvulsants, aminoglycosides)
- • History of malignant hyperthermia
- • Respiratory disorders, including sleep apnea
- • Allergy to anesthetic drugs used in the study
About Ankara City Hospital Bilkent
Ankara City Hospital Bilkent is a leading healthcare institution in Turkey, dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Equipped with state-of-the-art facilities and a multidisciplinary team of experienced professionals, the hospital fosters a collaborative environment for conducting rigorous scientific investigations. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of integrity, ultimately contributing to the development of new therapies and enhancing the quality of care provided to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Emine Emen, ass. Dr.
Study Chair
Ankara City Hospital Bilkent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported